References
- 1. Gupta V. Metallo beta lactamases in Pseudomonasaeruginosa and Acinetobacter species. Expert Opin Investig Drugs. 2008 Feb; 17(2):131-43.
- 2. Walsh TR, Toleman MA, Poirel L, Nordmann P. Metallo- β-lactamases: the quiet before the storm? Clin Microbiol Rev. 2005 Apr; 18:306-325.
- 3. Walsh F, Amyes SG. Carbapenem resistance in clinical isolates of Pseudomonas aeruginosa. J Chemother. 2007 Aug; 19:376-381.
- 4. Cornaglia G, Giamarellou H, Rossolini GM. Metallo- β-lactamases: a last frontier for β-lactams? Lancet Infect Dis. 2011 May; 11(5):381-393.
- 5. Giakkoupi P, Petrikkos G, Tzouvelekis L, Tsonas S, Legakis N, Vatopoulos A. Spread of integron-associated VIM-type metallo-β-lactamase genes among imipenemnonsusceptible Pseudomonas aeruginosa strains in Greek hospitals. J Clin Microbiol. 2003 Feb; 41(2): 822-825.
- 6. Rossolini GM, Luzzaro F, Migliavacca R, Mugnaioli C, Pini B, De Luca F, et al. First countrywide survey of acquired metallo-β-lactamases in gram-negative pathogens in Italy. Antimicrob Agents Chemother. 2008 Nov; 52(11):4023-4029.
- 7. Hocquet D, Plésiat P, Dehecq B, Mariotte P, Talon D, Bertrand X. Nationwide investigation of extended-spectrum β-lactamases, metallo-β-lactamases, and extended- spectrum oxacillinases produced by ceftazidime- resistant Pseudomonas aeruginosa strains in France. Antimicrob Agents Chemother. 2010 Aug; 54(8):3512-3515.
- 8. Valenza G, Joseph B, Elias J, Heike C, Oesterlein A, Engelhardt K, et al. First survey of metallo-beta-lactamases in clinical isolates of Pseudomonas aeruginosa in a German university hospital. Antimicrob Agents Chemother. 2010 Aug; 54(8): 3493-3497.
- 9. www.lahey.org/Studies
- 10. Poirel L, Naas T, Nicolas D, Collet L, Bellais S, Cavallo JD, et al. Characterization of VIM-2, a carbapenem- hydrolyzing metallo-β-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob Agents Chemother. 2000 Apr; 44(4):891-897.
- 11. Zhao WH, Hu ZQ. Epidemiology and genetics of VIM-type metallo-β-lactamases in Gram-negative bacilli. Future Microbiol. 2011 Mar; 6(3):317-333.
- 12. Elias J, Schoen C, Heinze G, Valenza G, Gerharz E, Riedmiller H, et al. Nosocomial outbreak of VIM-2 metallo- β-lactamase-producing Pseudomonas aeruginosa associated with retrograde urography. Clin Microbiol Infect. 2010 Sept; 16(9):1494-1500.
- 13. Van der Bij A, Van Mansfeld R, Peirano G, Goessens W, Severin J, Pitout J, et al. First outbreak of VIM-2 metallo- β-lactamase-producing Pseudomonas aeruginosa in The Netherlands: microbiology, epidemiology and clinical outcomes. Int J Antimicrob Agents. 2011 Jun; 37(6):513-518.
- 14. Viedma E, Juan C, Villa J, Barrado L, Orellana MA, Sanz F, et al. VIM-2-producing multidrug-resistant Pseudomonasaeruginosa ST175 clone, Spain. Emerg Infect Dis. 2012 Aug; 18(8): 1235-1241.
- 15. Cernat R, Balotescu C, Lazar V, Banu O, Ivanescu D, Bucur M. Genetic characterisation of highly prevalent MBLs and OXA carbapenemases in multidrug-resistant Acinetobacter baumannii strains in a Romanian hospital. Clin Microbiol Infect. 2007 Apr; 13(s1):O436.
- 16. Mereuta AI, Docquier JD, Rossolini GM, Buiuc D. Detection of metallo-beta-lactamases in gram-negative bacilli isolated in hospitals from Romania-research fellowship report. Bacteriol Virusol Parazitol Epidemiol. 2007 Jan-Jun; 52:45-49.
- 17. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 22th informational supplement. 2012. CLSI M100-S22, Wayne, PA.
- 18. Migliavacca R, Docquier JD, Mugnaioli C, Amicosante G, Daturi R, Lee KW, et al. Simple microdilution test for detection of metallo-β-lactamase production in Pseudomonas aeruginosa. J Clin Microbiol. 2002 Nov; 40(11):4388-4390.
- 19. Docquier JD, Riccio ML, Mugnaioli C, Luzzaro F, Endimiani A, Toniolo A, et al. IMP-12, a new plasmid encoded metallo-β-lactamase from a Pseudomonas putida clinical isolate. Antimicrob Agents Chemother. 2003 May; 47(5):1522-1528.
- 20. Nordmann P, Poirel L, Carrër A, Toleman MA, Walsh TR. How to detect NDM-1 producers. J Clin Microbiol. 2011 Feb; 49(2): 718-721.
- 21. Campbell M, Mahenthiralingam E, Speert DP. Evaluation of Random Amplified Polymorphic DNA Typing of Pseudomonas aeruginosa. J Clin Microbiol. 2000 Dec; 38 (12):4614-4615.
- 22. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug- resistant and pandrug-resistant: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012 Mar; 18(3): 268-281.
- 23. Zhao WH, Chen G, Ito R, Hu ZQ. Relevance of resistance levels to carbapenems and integron-borne blaIMP-1, blaIMP-7, blaIMP-10 and blaVIM-2 in clinical isolates of Pseudomonasaeruginosa. J Med Microbiol. 2009 Aug; 58(8):1080-1085.
- 24. Franco MRG, Caiaffa-Filho HH, Burattini MN, Rossi F. Metallo-beta-lactamases among imipenem-resistant Pseudomonas aeruginosa in a Brazilian university hospital. Clinics. 2010; 65(9):825-829.
- 25. Jovcic B, Vasiljevcic Z, Djukic S, Topisirovic L, Kojic M. Emergence of VIM-2 metallo-beta-lactamase-producing Pseudomonas aeruginosa isolates in a paediatric hospital in Serbia. J Med Microbiol. 2011 Jun; 60(6): 868-869.
- 26. Ratkai C, Quinteira S, Grosso F, Monteiro N, Nagy E, Peixe L. Controlling for false positives: interpreting MBL Etest and MBL combined disc test for the detection of metallo-β-lactamases. J Antimicrob Chemother. 2009 Sept; 64(3):657-658.
- 27. Samuelsen O, Buarø L, Giske CG, Simonsen GS, Aasnaes B, Sundsfjord A. Evaluation of phenotypic tests for the detection of metallo-β-lactamase-producing Pseudomonasaeruginosa in a low prevalence country. J Antimicrob Chemother. 2008 Apr; 61(4):827-830.
- 28. Khosravi Y, Tay ST, Vadivelu J. Analysis of integrons and associated gene cassettes of metallo-β-lactamase- positive Pseudomonas aeruginosa in Malaysia. J Med Microbiol. 2011 Jul; 60 (7):988-994.
- 29. Hammami S, Gautier V, Ghozzi R, Da Costa A, Ben- Redjeb S, Arlet G. Diversity in VIM-2-encoding class 1 integrons and occasional blaSHV2a carriage in isolates of a persistent, multidrug-resistant Pseudomonas aeruginosa clone from Tunis. Clin Microbiol Infect. 2010 Feb; 16(2):189-193.
- 30. Straut M, Dinu S, Cretoiu S, Lixandru B, Surdeanu M. Molecular characterization of genetic structures surrounding blaVIM-2 gene identified in Pseudomonas aeruginosa clinical isolates from Romania. Clin Microbiol Infect. 2010 Apr; 16(S2):197.
- 31. Toleman MA, Vinodh H, Sekar U, Kamat V, Walsh TR. blaVIM-2 - harbouring integrons isolated in India, Russia and United States arise from an ancestral class 1 integron predating the formation of 3' conserved sequence. Antimicrob Agents Chemother. 2007 Jul; 51(7): 2336-2638.